US FDA approves Vanda Pharmaceuticals’ motion sickness drug
Dec 30 (Reuters) – Vanda Pharmaceuticals (VNDA.O), opens new tab said on Tuesday its drug for the prevention…
FDA approves BioCryst’s oral pellet version of swelling disorder drug for children
Dec 12 (Reuters) – The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst…
US FDA awards six more fast-track vouchers to speed drug reviews
Nov 6 (Reuters) – The U.S. Food and Drug Administration said on Thursday it has awarded six more…